(20S)-ginsenoside Rg3 multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC6A2 protein] CTD PMID:24394491 (R)-noradrenaline multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 N-Methyl-3 more ... CTD PMID:11082428 more ... (R)-noradrenaline increases uptake ISO SLC6A2 (Homo sapiens) 6480464 SLC6A2 protein results in increased uptake of Norepinephrine CTD PMID:30776375 (R)-noradrenaline multiple interactions EXP 6480464 [Cullen corylifolium extract results in decreased activity of SLC6A2 protein] which results in decreased uptake of Norepinephrine and Norepinephrine affects the localization of and affects the metabolism of SLC6A2 protein CTD PMID:16338971 and PMID:17555897 (R)-noradrenaline multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [Desipramine results in decreased activity of SLC6A2 protein] which results in decreased abundance of Norepinephrine more ... CTD PMID:16725121 (R)-noradrenaline decreases expression ISO SLC6A2 (Homo sapiens) 6480464 Norepinephrine results in decreased expression of SLC6A2 protein CTD PMID:11082428 (R)-noradrenaline decreases uptake ISO SLC6A2 (Homo sapiens) 6480464 SLC6A2 mutant form results in decreased uptake of Norepinephrine CTD PMID:11458707 (R)-noradrenaline decreases activity ISO SLC6A2 (Homo sapiens) 6480464 Norepinephrine results in decreased activity of SLC6A2 protein CTD PMID:11082428 (R)-octopamine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Desipramine inhibits the reaction [SLC6A2 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 (S)-amphetamine affects response to substance ISO SLC6A2 (Homo sapiens) 6480464 SLC6A2 gene SNP affects the susceptibility to Dextroamphetamine CTD PMID:17239355 (S)-amphetamine decreases activity ISO SLC6A2 (Homo sapiens) 6480464 Dextroamphetamine results in decreased activity of SLC6A2 protein CTD PMID:30776375 (S)-amphetamine multiple interactions EXP 6480464 Dextroamphetamine inhibits the reaction [SLC6A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:24841869 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC6A2 mRNA CTD PMID:34747641 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,5-dimethoxy-4-bromophenethylamine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 2-(4-bromo-2 more ... CTD PMID:28506818 2-phenylethylamine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 SLC6A2 protein promotes the reaction [phenethylamine results in increased activity of TAAR1 protein] CTD PMID:17234900 3,4-methylenedioxymethamphetamine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 N-Methyl-3 more ... CTD PMID:28506818 more ... 3,4-methylenedioxymethamphetamine affects response to substance ISO SLC6A2 (Homo sapiens) 6480464 SLC6A2 gene SNP affects the susceptibility to N-Methyl-3 and 4-methylenedioxyamphetamine CTD PMID:29198060 3,4-methylenedioxymethamphetamine decreases activity ISO SLC6A2 (Homo sapiens) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased activity of SLC6A2 protein CTD PMID:30776375 4,4'-sulfonyldiphenol increases expression ISO Slc6a2 (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SLC6A2 mRNA CTD PMID:30951980 aflatoxin B1 increases methylation ISO SLC6A2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SLC6A2 intron CTD PMID:30157460 aminorex multiple interactions EXP 6480464 Aminorex inhibits the reaction [SLC6A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:24841869 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC6A2 mRNA CTD PMID:16483693 amphetamine decreases expression ISO SLC6A2 (Homo sapiens) 6480464 Amphetamine results in decreased expression of SLC6A2 protein CTD PMID:11082428 amphetamine affects response to substance ISO SLC6A2 (Homo sapiens) 6480464 SLC6A2 SNP affects the susceptibility to Amphetamine CTD PMID:19727679 amphetamine decreases activity ISO SLC6A2 (Homo sapiens) 6480464 Amphetamine results in decreased activity of SLC6A2 protein CTD PMID:11082428 amphetamine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Amphetamine inhibits the reaction [nisoxetine binds to SLC6A2 protein] more ... CTD PMID:11082428 and PMID:28506818 antimycin A increases expression ISO SLC6A2 (Homo sapiens) 6480464 Antimycin A results in increased expression of SLC6A2 mRNA CTD PMID:33512557 Aroclor 1254 multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [Plant Extracts co-treated with Terpenes co-treated with ginsenoside Rg3] inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC6A2 protein] CTD PMID:24394491 Aroclor 1254 decreases expression ISO Slc6a2 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC6A2 protein CTD PMID:24394491 arsane decreases expression ISO Slc6a2 (Mus musculus) 6480464 Arsenic results in decreased expression of SLC6A2 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO Slc6a2 (Mus musculus) 6480464 Arsenic results in decreased expression of SLC6A2 mRNA CTD PMID:19654921 arsenous acid decreases response to substance ISO SLC6A2 (Homo sapiens) 6480464 SLC6A2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 belinostat increases expression ISO SLC6A2 (Homo sapiens) 6480464 belinostat results in increased expression of SLC6A2 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO Slc6a2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SLC6A2 mRNA CTD PMID:21569818 and PMID:22228805 benzo[a]pyrene affects methylation ISO SLC6A2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC6A2 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO SLC6A2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC6A2 exon CTD PMID:27901495 benzo[b]fluoranthene decreases expression ISO Slc6a2 (Mus musculus) 6480464 benzo(b)fluoranthene results in decreased expression of SLC6A2 mRNA CTD PMID:26377693 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC6A2 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC6A2 gene CTD PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC6A2 gene CTD PMID:28505145 bisphenol F increases expression ISO Slc6a2 (Mus musculus) 6480464 bisphenol F results in increased expression of SLC6A2 mRNA CTD PMID:30951980 bupivacaine multiple interactions ISO Slc6a2 (Mus musculus) 6480464 Bupivacaine inhibits the reaction [[Desipramine results in decreased activity of SLC6A2 protein] which results in decreased abundance of Norepinephrine] CTD PMID:16725121 buta-1,3-diene increases expression ISO Slc6a2 (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of SLC6A2 mRNA CTD PMID:29038090 carbon nanotube affects expression ISO Slc6a2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carmustine increases expression ISO SLC6A2 (Homo sapiens) 6480464 Carmustine results in increased expression of SLC6A2 mRNA CTD PMID:15980968 CGP 52608 multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC6A2 gene] CTD PMID:28238834 chloroprene increases expression ISO Slc6a2 (Mus musculus) 6480464 Chloroprene results in increased expression of SLC6A2 mRNA CTD PMID:23125180 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of SLC6A2 mRNA CTD PMID:17452286 chlorpyrifos increases expression ISO Slc6a2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SLC6A2 mRNA CTD PMID:37019170 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of SLC6A2 mRNA CTD PMID:18812211 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of SLC6A2 mRNA CTD PMID:18923069 cobalt atom decreases expression ISO Slc6a2 (Mus musculus) 6480464 Cobalt results in decreased expression of SLC6A2 mRNA CTD PMID:34468815 cocaine decreases activity ISO SLC6A2 (Homo sapiens) 6480464 Cocaine results in decreased activity of SLC6A2 protein CTD PMID:11082428 cocaine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Cocaine inhibits the reaction [SLC6A2 protein results in increased import of Biogenic Monoamines analog] and Cocaine inhibits the reaction [SLC6A2 protein results in increased import of Fluorescent Dyes] CTD PMID:28506818 cocaine increases expression ISO Slc6a2 (Mus musculus) 6480464 Cocaine results in increased expression of SLC6A2 protein CTD PMID:25724654 cocaine increases phosphorylation ISO Slc6a2 (Mus musculus) 6480464 Cocaine results in increased phosphorylation of SLC6A2 protein CTD PMID:25724654 cocaine multiple interactions ISO Slc6a2 (Mus musculus) 6480464 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Cocaine results in increased expression of and results in increased phosphorylation of SLC6A2 protein] and SB 203580 inhibits the reaction [Cocaine results in increased expression of SLC6A2 protein] CTD PMID:25724654 cocaine increases response to substance ISO Slc6a2 (Mus musculus) 6480464 SLC6A2 protein results in increased susceptibility to Cocaine CTD PMID:15911120 cocaine increases expression ISO SLC6A2 (Homo sapiens) 6480464 Cocaine results in increased expression of SLC6A2 protein CTD PMID:15763139 and PMID:19728366 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of SLC6A2 mRNA CTD PMID:26033743 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of SLC6A2 mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of SLC6A2 mRNA CTD PMID:26033743 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of SLC6A2 mRNA CTD PMID:26033743 copper(II) sulfate increases expression ISO SLC6A2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of SLC6A2 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO Slc6a2 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of SLC6A2 mRNA CTD PMID:29279043 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SLC6A2 mRNA CTD PMID:23914054 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of SLC6A2 mRNA CTD PMID:23640034 desferrioxamine B decreases expression EXP 6480464 Deferoxamine results in decreased expression of SLC6A2 protein CTD PMID:16650837 desipramine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Desipramine inhibits the reaction [SLC6A2 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 desipramine decreases activity EXP 6480464 Desipramine results in decreased activity of SLC6A2 protein CTD PMID:18561912 desipramine decreases activity ISO Slc6a2 (Mus musculus) 6480464 Desipramine results in decreased activity of SLC6A2 protein CTD PMID:19616025 desipramine decreases expression ISO Slc6a2 (Mus musculus) 6480464 Desipramine results in decreased expression of SLC6A2 protein CTD PMID:18923402 desipramine multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [Desipramine binds to and results in decreased activity of SLC6A2 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium more ... CTD PMID:16725121 and PMID:20079841 dextran sulfate multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC6A2 mRNA CTD PMID:29950665 diarsenic trioxide decreases response to substance ISO SLC6A2 (Homo sapiens) 6480464 SLC6A2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of SLC6A2 mRNA CTD PMID:18812211 dopamine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Desipramine inhibits the reaction [SLC6A2 protein promotes the reaction [Dopamine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 dopamine increases uptake ISO Slc6a2 (Mus musculus) 6480464 SLC6A2 protein results in increased uptake of Dopamine CTD PMID:20626558 elemental selenium decreases expression ISO SLC6A2 (Homo sapiens) 6480464 Selenium results in decreased expression of SLC6A2 mRNA CTD PMID:19244175 Erionite decreases expression ISO Slc6a2 (Mus musculus) 6480464 erionite results in decreased expression of SLC6A2 mRNA CTD PMID:29279043 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of SLC6A2 mRNA CTD PMID:18035473 fluoxetine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Fluoxetine inhibits the reaction [SLC6A2 protein results in increased import of Biogenic Monoamines analog] and Fluoxetine inhibits the reaction [SLC6A2 protein results in increased import of Fluorescent Dyes] CTD PMID:28506818 folic acid decreases expression ISO Slc6a2 (Mus musculus) 6480464 Folic Acid results in decreased expression of SLC6A2 mRNA CTD PMID:25629700 fonofos increases methylation ISO SLC6A2 (Homo sapiens) 6480464 Fonofos results in increased methylation of SLC6A2 promoter CTD PMID:22847954 fulvestrant multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC6A2 gene CTD PMID:31601247 genistein decreases expression ISO Slc6a2 (Mus musculus) 6480464 Genistein results in decreased expression of SLC6A2 mRNA CTD PMID:32186404 hydralazine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC6A2 mRNA CTD PMID:17183730 hydrazine decreases expression ISO Slc6a2 (Mus musculus) 6480464 hydrazine results in decreased expression of SLC6A2 mRNA CTD PMID:15282401 hydrogen sulfide decreases expression ISO Slc6a2 (Mus musculus) 6480464 Hydrogen Sulfide results in decreased expression of SLC6A2 mRNA CTD PMID:31843631 kainic acid increases response to substance ISO Slc6a2 (Mus musculus) 6480464 SLC6A2 protein results in increased susceptibility to Kainic Acid CTD PMID:15911120 ketamine multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [Ketamine co-treated with Xylenes] results in decreased activity of SLC6A2 protein CTD PMID:17934728 ketamine decreases activity ISO Slc6a2 (Mus musculus) 6480464 Ketamine results in decreased activity of SLC6A2 protein CTD PMID:17934728 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of SLC6A2 mRNA CTD PMID:21864555 lead(0) decreases expression ISO SLC6A2 (Homo sapiens) 6480464 Lead results in decreased expression of SLC6A2 mRNA CTD PMID:19921347 lidocaine multiple interactions ISO Slc6a2 (Mus musculus) 6480464 Lidocaine inhibits the reaction [[Desipramine results in decreased activity of SLC6A2 protein] which results in decreased abundance of Norepinephrine] CTD PMID:16725121 maneb multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [Paraquat co-treated with Maneb] affects the expression of SLC6A2 mRNA CTD PMID:22563483 methamphetamine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Desipramine inhibits the reaction [SLC6A2 protein promotes the reaction [Methamphetamine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 monensin A multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]] CTD PMID:29908239 mono(2-ethylhexyl) phthalate decreases expression ISO Slc6a2 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of SLC6A2 mRNA CTD PMID:22401849 monosodium L-glutamate increases expression ISO Slc6a2 (Mus musculus) 6480464 Sodium Glutamate results in increased expression of SLC6A2 mRNA CTD PMID:22078008 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of SLC6A2 gene CTD PMID:33148267 N-methyl-4-phenylpyridinium multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [Desipramine binds to and results in decreased activity of SLC6A2 protein] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium CTD PMID:20079841 N-methyl-4-phenylpyridinium multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]] more ... CTD PMID:29908239 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 4-methylaminorex inhibits the reaction [SLC6A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] more ... CTD PMID:24841869 N-methyl-4-phenylpyridinium increases uptake ISO SLC6A2 (Homo sapiens) 6480464 SLC6A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium CTD PMID:29908239 N-methyl-4-phenylpyridinium increases uptake EXP 6480464 SLC6A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium CTD PMID:24841869 N-methyl-4-phenylpyridinium affects expression ISO SLC6A2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium affects the expression of SLC6A2 mRNA CTD PMID:12710931 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of SLC6A2 mRNA CTD PMID:18812211 nickel atom decreases expression ISO SLC6A2 (Homo sapiens) 6480464 Nickel results in decreased expression of SLC6A2 mRNA CTD PMID:24768652 and PMID:25583101 nisoxetine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Amphetamine inhibits the reaction [nisoxetine binds to SLC6A2 protein] and Norepinephrine inhibits the reaction [nisoxetine binds to SLC6A2 protein] CTD PMID:11082428 nortriptyline affects response to substance ISO SLC6A2 (Homo sapiens) 6480464 SLC6A2 gene polymorphism affects the susceptibility to Nortriptyline CTD PMID:17018806 octopamine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Desipramine inhibits the reaction [SLC6A2 protein promotes the reaction [Octopamine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 ozone multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SLC6A2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLC6A2 mRNA CTD PMID:34911549 paraquat multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [Paraquat co-treated with Maneb] affects the expression of SLC6A2 mRNA CTD PMID:22563483 parathion increases methylation ISO SLC6A2 (Homo sapiens) 6480464 Parathion results in increased methylation of SLC6A2 promoter CTD PMID:22847954 PCB138 multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 pentetrazol increases response to substance ISO Slc6a2 (Mus musculus) 6480464 SLC6A2 protein results in increased susceptibility to Pentylenetetrazole CTD PMID:15911120 perfluorononanoic acid affects methylation ISO SLC6A2 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid affects the methylation of SLC6A2 gene CTD PMID:35266797 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of SLC6A2 gene CTD PMID:33148267 pirinixic acid multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC6A2 mRNA CTD PMID:19710929 protriptyline decreases expression ISO Slc6a2 (Mus musculus) 6480464 Protriptyline results in decreased expression of SLC6A2 protein CTD PMID:18923402 reboxetine decreases expression ISO Slc6a2 (Mus musculus) 6480464 reboxetine results in decreased expression of SLC6A2 protein CTD PMID:18923402 reserpine decreases expression EXP 6480464 Reserpine results in decreased expression of SLC6A2 mRNA CTD PMID:7478180 and PMID:7616203 resveratrol multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC6A2 mRNA CTD PMID:23557933 SB 203580 multiple interactions ISO Slc6a2 (Mus musculus) 6480464 SB 203580 inhibits the reaction [Cocaine results in increased expression of SLC6A2 protein] CTD PMID:25724654 selenium atom decreases expression ISO SLC6A2 (Homo sapiens) 6480464 Selenium results in decreased expression of SLC6A2 mRNA CTD PMID:19244175 serotonin multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 SLC6A2 protein promotes the reaction [Serotonin results in increased activity of TAAR1 protein] CTD PMID:17234900 sodium arsenite decreases expression ISO SLC6A2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of SLC6A2 mRNA CTD PMID:34032870 terbufos increases methylation ISO SLC6A2 (Homo sapiens) 6480464 terbufos results in increased methylation of SLC6A2 promoter CTD PMID:22847954 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of SLC6A2 mRNA CTD PMID:12734012 titanium dioxide decreases expression ISO Slc6a2 (Mus musculus) 6480464 titanium dioxide results in decreased expression of SLC6A2 mRNA CTD PMID:23557971 and PMID:29264374 titanium dioxide multiple interactions ISO Slc6a2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC6A2 mRNA CTD PMID:29950665 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of SLC6A2 mRNA CTD PMID:30012374 tremolite asbestos decreases expression ISO Slc6a2 (Mus musculus) 6480464 tremolite results in decreased expression of SLC6A2 mRNA CTD PMID:29279043 tricaine multiple interactions ISO Slc6a2 (Mus musculus) 6480464 tricaine inhibits the reaction [[Desipramine results in decreased activity of SLC6A2 protein] which results in decreased abundance of Norepinephrine] CTD PMID:16725121 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC6A2 mRNA CTD PMID:33387578 triclosan increases expression ISO SLC6A2 (Homo sapiens) 6480464 Triclosan results in increased expression of SLC6A2 mRNA CTD PMID:30510588 tryptamine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Desipramine inhibits the reaction [SLC6A2 protein promotes the reaction [tryptamine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 tyramine multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 Desipramine inhibits the reaction [SLC6A2 protein promotes the reaction [Tyramine results in increased activity of TAAR1 protein]] more ... CTD PMID:17234900 valproic acid multiple interactions ISO SLC6A2 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC6A2 mRNA CTD PMID:17183730 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC6A2 mRNA CTD PMID:23869203 vitamin E decreases expression ISO SLC6A2 (Homo sapiens) 6480464 Vitamin E results in decreased expression of SLC6A2 mRNA CTD PMID:19244175 zidovudine increases expression ISO SLC6A2 (Homo sapiens) 6480464 Zidovudine results in increased expression of SLC6A2 mRNA CTD PMID:24292225 zinc sulfate increases expression ISO SLC6A2 (Homo sapiens) 6480464 Zinc Sulfate results in increased expression of SLC6A2 mRNA CTD PMID:16330358
